11.20.14
Dublin, Ireland-based Covidien plc has earned CE mark for the Nellcor bedside SpO2 patient monitoring system, PM100N. The system currently is available in the European Economic Area (EEA), Australia and New Zealand. The system is a bedside pulse oximetry (SpO2) monitor featuring home care and sleep study modes that complies with standards for medical electrical equipment used in the home health care environment.
The new system provides continuous monitoring of blood oxygenation and pulse rate to help clinicians detect and respond to dangerous respiratory events sooner, along with patient trend data to allow clinicians to evaluate a patient's clinical course. The system is designed to provide accurate and reliable pulse oximetry readings even during low patient perfusion, motion and other forms of signal interference.
“At Covidien, we’re dedicated to improving patient care and safety, not only in the hospital, but also in home health care,” said Matt Anderson, vice president and general manager of patient monitoring, respiratory and monitoring solutions for Covidien.
The pulse oximetry system incorporates SatSeconds Alarm Management technology—available only on Covidien patient monitors— to help distinguish between serious and minor events, reducing clinically insignificant desaturation alarms. The monitor can also be password-protected to prevent lay users from inadvertently modifying settings.
“Just because a patient is not in the hospital setting does not mean he or she no longer needs on-going care,” said Scott Kelley, M.D., chief medical officer of respiratory and monitoring solutions for Covidien. “The availability of solutions to enable safe, quality care for patients in all settings, including the home, is something we are focused on at Covidien. This new system includes all of the leading Nellcor technology that clinicians have trusted for more than 30 years, with additional features that make it well suited to the home health care environment.”
The new system provides continuous monitoring of blood oxygenation and pulse rate to help clinicians detect and respond to dangerous respiratory events sooner, along with patient trend data to allow clinicians to evaluate a patient's clinical course. The system is designed to provide accurate and reliable pulse oximetry readings even during low patient perfusion, motion and other forms of signal interference.
“At Covidien, we’re dedicated to improving patient care and safety, not only in the hospital, but also in home health care,” said Matt Anderson, vice president and general manager of patient monitoring, respiratory and monitoring solutions for Covidien.
The pulse oximetry system incorporates SatSeconds Alarm Management technology—available only on Covidien patient monitors— to help distinguish between serious and minor events, reducing clinically insignificant desaturation alarms. The monitor can also be password-protected to prevent lay users from inadvertently modifying settings.
“Just because a patient is not in the hospital setting does not mean he or she no longer needs on-going care,” said Scott Kelley, M.D., chief medical officer of respiratory and monitoring solutions for Covidien. “The availability of solutions to enable safe, quality care for patients in all settings, including the home, is something we are focused on at Covidien. This new system includes all of the leading Nellcor technology that clinicians have trusted for more than 30 years, with additional features that make it well suited to the home health care environment.”